Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Large Blend · New York Life Investments

NYLI Epoch U.S. Equity Yield Fund SIMPLE CLASS (EPLMX)

Ticker EPLMX · Since 2020-08-31 · · Holdings as of Jul 31, 2026

Expense ratio
1.3%$130/yr per $10k
5-yr return
+11.2%annualized
1-yr return
+13.4%as of Dec 2025
Net assets
$1.2Ball share classes
Holdings
111

Bottom line

Is EPLMX a good fund? The bottom line

EPLMX is the SIMPLE CLASS share class of NYLI Epoch U.S. Equity Yield Fund, a managed large blend mutual fund from New York Life Investments.

Its expense ratio is 1.3% — about $130 a year on every $10,000 invested, more expensive than 77% of large blend funds we track.

It returned +13.4% over one year, +11.2% a year over five years (as of Dec 31, 2025, per its prospectus).

With $1.2 billion in net assets and 111 holdings, its largest position is JPMorgan Chase & Co. (2.3%) and the top 10 make up 20% of the portfolio.

What stands out

  • No front-end sales load

What to watch

  • Expensive for its category (1.3%)
  • 12b-1 marketing fee of 0.5% a year

Updated Nov 19, 2026

What EPLMX invests in

The Fund seeks current income and capital appreciation.

"The Fund generally invests in a diversified portfolio consisting of equity securities of U.S. companies that have a history of attractive dividend yields and positive growth in operating cash flow. Under normal circumstances, the Fund invests at least 80% of its assets (net assets plus any borrowings for investment purposes) in equity securities of dividend-paying U.S. companies across all market capitalizations. The Fund may invest up to 15% of its net assets in foreign securities. An issuer of a security is considered to be a U.S. or foreign issuer based on the issuer's ""country of risk"" (or similar designation) as determined by a third-party such as Bloomberg . Equity or equity-related securities represent an ownership interest, or the right to acquire an ownership interest, in an issuer. Investment Process: Epoch Investment Partners, Inc., the Fund's Subadvisor, invests…

From the fund's prospectus (filed Feb 26, 2026).

EPLMX performance

Average annual total returns
1 yr5 yr10 yr
EPLMX+13.4%+11.2%—
Large Blend median+13.8%+9.7%+10.9%

Source: Fund prospectus, as of Dec 31, 2025

Full EPLMX performance history →

What EPLMX costs

On a $10,000 investment, EPLMX's 1.3% expense ratio costs about $130 a year. The prospectus estimates $1,568 in total costs over 10 years (assuming 5% annual returns). The median large blend fund charges 0.83%.

See the full EPLMX fee table →

EPLMX top 10 holdings

#Holding% of fund
1JPMorgan Chase & Co.2.27%
2Bank of America Corp.2.25%
3Cisco Systems, Inc.2.20%
4Dell Technologies, Inc.2.13%
5Johnson & Johnson2.02%
6CVS Health Corp.1.94%
7MetLife, Inc.1.87%
8Broadcom, Inc.1.84%
9AbbVie, Inc.1.78%
10Hewlett Packard Enterprise Co.1.72%

Source: SEC Form N-PORT, period ended Jul 31, 2026

The top 10 make up 20% of the fund. See all top 25 holdings and asset mix →

Alternatives to EPLMX

More funds like EPLMX →

EPLMX FAQ

What is the expense ratio of EPLMX?
EPLMX's expense ratio is 1.3%, which works out to about $130 a year for every $10,000 invested. The prospectus estimates total costs of $1,568 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is EPLMX a good investment?
It depends on your goals, but the data points to: no front-end sales load; expensive for its category (1.3%); 12b-1 marketing fee of 0.5% a year. This is general information, not personalized advice.
What does EPLMX hold?
EPLMX's largest holdings are JPMorgan Chase & Co. (2.3%), Bank of America Corp. (2.3%), Cisco Systems, Inc. (2.2%), Dell Technologies, Inc. (2.1%), Johnson & Johnson (2.0%). It holds 111 positions in total as of Jul 31, 2026 (SEC Form N-PORT).
What is EPLMX's 5-year return?
EPLMX returned +11.2% a year over the five years ending Dec 31, 2025. Past performance does not guarantee future results.
Does EPLMX have a sales load?
No. EPLMX has no front-end sales charge.
Who manages EPLMX?
EPLMX is offered by New York Life Investments through New York Life Investments Funds Trust.